Author: Arlene Weintraub
Source: Xconomy
Interest: When Cambridge, MA-based Warp Drive Bio launched on January 10, the startup was as notable for its financing structure as it was for its technology—maybe more. That’s because part of the $125 million in funding that Warp Drive received came from French pharmaceutical giant Sanofi (NYSE: SNY) , which received in return the chance to buy Warp Drive outright, sometime in the future, if certain milestones are met.
Link: http://www.xconomy.com/national/2012/02/13/option-to-buy-the-new-face-of-biotech-funding/
Loading...